日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Newly Launched Nationwide Database Revealed Real-World Evidence on Systemic Therapy for Unresectable Hepatocellular Carcinoma in Japan: Hepatoma Registry of Integrating and Aggregating Electronic Health Record (HERITAGE)

日本新推出的全国性数据库揭示了不可切除肝细胞癌系统治疗的真实世界证据:整合和汇总电子健康记录的肝癌登记处(HERITAGE)

Asaoka, Yoshinari; Tateishi, Ryosuke; Yamada, Yasuhide; Kokudo, Takashi; Saito, Akiko; Hasegawa, Kiyoshi; Iijima, Hiroko; Kato, Naoya; Shimada, Mitsuo; Hatano, Etsuro; Fukumoto, Takumi; Murakami, Takamichi; Yano, Hirohisa; Yoshimitsu, Kengo; Kurosaki, Masayuki; Sakamoto, Michiie; Matsuyama, Yutaka; Kudo, Masatoshi; Miyata, Hiroaki; Kokudo, Norihiro

Primary Analysis of a Phase II Study of Atezolizumab plus Bevacizumab for TACE-Unsuitable Patients with Tumor Burden beyond Up-To-Seven Criteria in Intermediate-Stage Hepatocellular Carcinoma: REPLACEMENT Study

一项针对不适合接受经导管动脉化疗栓塞术(TACE)且肿瘤负荷超过“Up-To-7”标准的中晚期肝细胞癌患者的阿特珠单抗联合贝伐珠单抗治疗的II期研究的主要分析:REPLACEMENT研究

Kudo, Masatoshi; Ueshima, Kazuomi; Tsuchiya, Kaoru; Yamashita, Tatsuya; Shimose, Shigeo; Numata, Kazushi; Kodama, Yuzo; Itoh, Shinji; Tanaka, Yasuhito; Kuroda, Hidekatsu; Aikata, Hiroshi; Hiraoka, Atsushi; Moriguchi, Michihisa; Tateishi, Ryosuke; Ogasawara, Sadahisa; Yamamoto, Kouji; Ikeda, Masafumi

Real-World Effectiveness of Tolvaptan for Hyponatremia in Cirrhosis Across Global Regions: A Target Trial Emulation

托伐普坦治疗肝硬化低钠血症的真实世界疗效:全球区域Target试验模拟

Okushin, Kazuya; Tateishi, Ryosuke; Fujishiro, Mitsuhiro; Tsutsumi, Takeya; Koike, Kazuhiko; Tanaka, Tomohiro

Deep learning and digital pathology powers prediction of HCC development in steatotic liver disease

深度学习和数字病理学助力预测脂肪肝疾病中肝细胞癌的发生发展

Nakatsuka, Takuma; Tateishi, Ryosuke; Sato, Masaya; Hashizume, Natsuka; Kamada, Ami; Nakano, Hiroki; Kabeya, Yoshinori; Yonezawa, Sho; Irie, Rie; Tsujikawa, Hanako; Sumida, Yoshio; Yoneda, Masashi; Akuta, Norio; Kawaguchi, Takumi; Takahashi, Hirokazu; Eguchi, Yuichiro; Seko, Yuya; Itoh, Yoshito; Murakami, Eisuke; Chayama, Kazuaki; Taniai, Makiko; Tokushige, Katsutoshi; Okanoue, Takeshi; Sakamoto, Michiie; Fujishiro, Mitsuhiro; Koike, Kazuhiko

AI-based phenotyping of hepatic fiber morphology to inform molecular alterations in metabolic dysfunction-associated steatotic liver disease.

基于人工智能的肝纤维形态表型分析,揭示代谢功能障碍相关脂肪肝疾病的分子改变

Fujiwara Naoto, Matsushita Yuki, Tempaku Mina, Tachi Yutaro, Kimura Genki, Izuoka Kiyora, Hayata Yuki, Kawamura Satoshi, Eguchi Akiko, Nakatsuka Takuma, Sato Masaya, Ono Atsushi, Murakami Eisuke, Tsuge Masataka, Oka Shiro, Hayashi Akinobu, Hirokawa Yoshifumi, Watanabe Masatoshi, Parikh Neehar D, Singal Amit G, Marrero Jorge A, Hoshida Yujin, Mizuno Shugo, Tateishi Ryosuke, Koike Kazuhiko, Fujishiro Mitsuhiro, Nakagawa Hayato

Comparative Study of Laparoscopic Hepatectomy, Open Hepatectomy, and Percutaneous Radiofrequency Ablation for Small Hepatocellular Carcinoma: An Ancillary Study of the SURF Trial

腹腔镜肝切除术、开腹肝切除术和经皮射频消融术治疗小型肝细胞癌的比较研究:SURF试验的辅助研究

Masuda, Takashi; Endo, Yuichi; Kawaguchi, Yoshikuni; Kashiwabara, Kosuke; Okamura, Yukiyasu; Kurosaki, Masayuki; Kudo, Masatoshi; Shimada, Mitsuo; Yamanaka, Naoki; Yamashita, Taro; Tateishi, Ryosuke; Shiina, Shuichiro; Fujishiro, Mitsuhiro; Matsuyama, Yutaka; Omata, Masao; Kokudo, Norihiro; Hasegawa, Kiyoshi; Inomata, Masafumi

Asian Conference on Tumor Ablation Guidelines for Hepatocellular Carcinoma

亚洲肝细胞癌肿瘤消融指南会议

Shiina, Shuichiro; Tateishi, Ryosuke; Choi, Joon Il; Kim, So Yeon; Meng, Zhiqiang; Shen, Lujun; Lu, Sheng-Nan; Hwang, Jen-I; Tobari, Maki; Maruyama, Hitoshi; Batsaikhan, Terguunbileg; Deng, Qing; Canseco, Lariza Marie; Asaoka, Yoshinari; Lin, Shi-Ming; Huang, Kai-Wen; Rhim, Hyunchul; Liang, Ping; Pua, Uei; Tanaka, Masatoshi; Wu, Peihong

The Risk of Decompensation in Steatotic Liver Disease-Related Hepatocellular Carcinoma: A Comparison with Viral-Controlled Cases

脂肪肝相关肝细胞癌失代偿风险:与病毒控制病例的比较

Matsushita, Yuki; Minami, Tatsuya; Kawaguchi, Yoshikuni; Ichida, Akihiko; Oikawa, Ryo; Mabuchi, Keisuke; Moriyama, Makoto; Yamada, Tomoharu; Okushin, Kazuya; Nakatsuka, Takuma; Sato, Masaya; Kudo, Yotaro; Fujishiro, Mitsuhiro; Hasegawa, Kiyoshi; Tateishi, Ryosuke

Atezolizumab Plus Bevacizumab for TACE-Unsuitable Intermediate-Stage HCC Beyond Up-To-7 Criteria: Final Analysis of REPLACEMENT

阿特珠单抗联合贝伐珠单抗治疗不适合经TACE治疗且超出Up-To-7标准的中晚期肝细胞癌:REPLACEMENT研究的最终分析

Ueshima, Kazuomi; Tsuchiya, Kaoru; Yamashita, Tatsuya; Shimose, Shigeo; Numata, Kazushi; Kodama, Yuzo; Itoh, Shinji; Tanaka, Yasuhito; Kuroda, Hidekatsu; Ohkawa, Kazuyoshi; Kuzuya, Teiji; Ikeda, Masafumi; Kooka, Youhei; Aikata, Hiroshi; Hiraoka, Atsushi; Moriguchi, Michihisa; Tateishi, Ryosuke; Ogasawara, Sadahisa; Yamamoto, Kouji; Kudo, Masatoshi

Anti-Angiogenic Agents for Advanced Hepatocellular Carcinoma Induce Liver Atrophy

抗血管生成药物治疗晚期肝细胞癌可诱发肝萎缩

Wake, Taijiro; Yamada, Tomoharu; Tateishi, Ryosuke; Moriyama, Makoto; Matsushita, Yuki; Okushin, Kazuya; Nakatsuka, Takuma; Sato, Masaya; Minami, Tatsuya; Kudo, Yotaro; Fujishiro, Mitsuhiro